Mohammad Talaei
Overview
Explore the profile of Mohammad Talaei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sadeghi M, Sheikhbahaei E, Talaei M, Gholamrezaei A, Sharif S, Roohafza H
J Tehran Heart Cent
. 2023 May;
17(4):195-201.
PMID: 37143755
Background: We aimed to investigate the association between persistent early repolarization (ER) in healthy individuals and long-term cardiovascular events and mortality rates in a large cohort study. Methods: Demographic characteristics,...
12.
Mehrabani-Zeinabad K, Feizi A, Sadeghi M, Roohafza H, Talaei M, Sarrafzadegan N
BMC Med Inform Decis Mak
. 2023 Apr;
23(1):72.
PMID: 37076833
Background: Cardiovascular diseases (CVD) are the predominant cause of early death worldwide. Identification of people with a high risk of being affected by CVD is consequential in CVD prevention. This...
13.
Talaei M, Emmett P, Granell R, Tabatabaeian H, Northstone K, Bergstrom A, et al.
Respir Res
. 2023 Mar;
24(1):82.
PMID: 36927379
Background: Longitudinal epidemiological data are scarce examining the relationship between dietary patterns and respiratory outcomes in childhood. We investigated whether three distinct dietary patterns in mid-childhood were associated with lung...
14.
Holt H, Jolliffe D, Talaei M, Faustini S, Vivaldi G, Greenig M, et al.
NPJ Vaccines
. 2023 Feb;
8(1):26.
PMID: 36841835
Prospective population-based studies investigating associations between reactive symptoms following SARS-CoV-2 vaccination and serologic responses to vaccination are lacking. We therefore conducted a study in 9003 adults from the UK general...
15.
Tydeman F, Pfeffer P, Vivaldi G, Holt H, Talaei M, Jolliffe D, et al.
Thorax
. 2022 Nov;
78(8):752-759.
PMID: 36423925
Background: The imposition of restrictions on social mixing early in the COVID-19 pandemic was followed by a reduction in asthma exacerbations in multiple settings internationally. Temporal trends in social mixing,...
16.
Jolliffe D, Faustini S, Holt H, Perdek N, Maltby S, Talaei M, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298466
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of sociodemographic, behavioural, clinical, pharmacologic and nutritional factors could explain these differences. To investigate this hypothesis,...
17.
Jolliffe D, Holt H, Greenig M, Talaei M, Perdek N, Pfeffer P, et al.
BMJ
. 2022 Oct;
378:e071230.
PMID: 36215226
Objective: To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) <75 nmol/L) on risk of all cause...
18.
Holt H, Relton C, Talaei M, Symons J, Davies M, Jolliffe D, et al.
Int J Epidemiol
. 2022 Sep;
52(1):e46-e56.
PMID: 36174228
No abstract available.
19.
Vivaldi G, Jolliffe D, Holt H, Tydeman F, Talaei M, Davies G, et al.
Lancet Reg Health Eur
. 2022 Sep;
22:100501.
PMID: 36168404
Background: Little is known about how demographic, behavioural, and vaccine-related factors affect risk of post-vaccination SARS-CoV-2 infection. We aimed to identify risk factors for SARS-CoV-2 infection after primary and booster...
20.
Vivaldi G, Jolliffe D, Faustini S, Shields A, Holt H, Perdek N, et al.
J Infect Dis
. 2022 Jul;
226(11):1903-1908.
PMID: 35906930
In this population-based cohort of 7538 adults, combined immunoglobulin (Ig) G, IgA, and IgM (IgG/A/M) anti-spike titers measured after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination were predictive of...